SCHEMBL8614933

SCHEMBL8614933

NC(=Nc1ccccc1)NC(=O)c1ccnc2cc([N+](=O)[O-])ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
KMT2A Q03164 7/20 0.41
MAPT P10636 6/20 0.41
MEN1 O00255 6/20 0.41
GAA P10253 1/20 0.41
ALDH1A1 P00352 7/20 0.41
TP53 P04637 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
LMNA P02545 3/20 0.39
HTT P42858 2/20 0.39
KDM4E B2RXH2 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
SCNN1A P37088 1/20 0.39
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
PSMD14 O00487 1/20 0.38
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8619779 0.92 CCNC (0.45) EGFRNPC1RAB9AKMT2AMAPT
SCHEMBL8615213 0.86 RAB9A (0.42) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL8615943 0.84 RAB9A (0.45) EGFRNPC1RAB9AKMT2AMAPT
SCHEMBL8619393 0.83 SMN1; SMN2 (0.46) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL8618237 0.83 ALK (0.43) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL8617741 0.83 SCN2A (0.44) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL8616502 0.80 KDM4E (0.48) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL8615687 0.79 RAB9A (0.42) NPC1RAB9AKMT2AMAPTMEN1
SCHEMBL8616316 0.79 SMN1; SMN2 (0.47) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL8612684 0.79 CSF1R (0.42) EGFRNPC1RAB9AKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed